BMRN EPS Estimates
BioMarin Pharmaceutical Inc.
$57.30
+$2.16(+3.92%)
48
Overall
65
Value
27
Tech
52
Quality
Market Cap
$10.67B
Volume
216.80K
52W Range
$49.26 - $70.98
Target Price
$90.77
BMRN EPS estimates: the consensus estimate for BioMarin Pharmaceutical Inc.'s current fiscal year is $4.10 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BMRN EPS Estimates
- EPS estimate, current quarter
- $1.13
- EPS estimate, next quarter
- $1.47
- EPS estimate, current year
- $4.10
- EPS estimate, next year
- $5.42
- EPS growth, 3-year
- +33.79%
| Fiscal year | EPS |
|---|---|
| 2025 | $1.82 |
| 2024 | $2.25 |
| 2023 | $0.89 |
| 2022 | $0.76 |
| 2021 | $-0.35 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMRN | $57.30 | +3.9% | 216.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioMarin Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW